Table 6.
Linear-kernel SVR performances based on leave-one out cross-validation to correlate Δrs-FC between two time-points with Δ behavioral measures between corresponding time-points are presented.
| Outcome | Δrs-FCT6−T4~ΔbehaviorT6−T4 | Δrs-FCT7−T4~ΔbehaviorT7−T4 | Δrs-FCT7−T6~Δbehavior T7−T6 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Features | RMSE | R2 | Features | RMSE | R2 | Features | RMSE | R2 | |
| (A) WITHOUT CLINICAL VARIABLES | |||||||||
| Δ9HPT(A) | 3 | 110.93 | 0.22 | 1 | 116.69 | 0.14 | 4 | 109.25 | 0.25 |
| Δ9HPT(U) | 1 | 4.2 | 0.28 | 1 | 4.05 | 0.26 | 6 | 2.86 | 0.63 |
| ΔARAT(A) | 7 | 20.58* | 0.33 | 4 | 17.87* | 0.49 | 6 | 15.48* | 0.61 |
| ΔBI | 5 | 8.01 | 0.18 | 5 | 0.05 | 0.53 | 6 | 6.39 | 0.3 |
| ΔSIS(ADL) | 2 | 10.93 | 0.24 | 5 | 10.62 | 0.51 | 8 | 0.08 | 0.73 |
| ΔSIS(HF) | 5 | 8.52* | 0.26 | 4 | 26.84* | 0.36 | 6 | 33.47* | 0.42 |
| ΔSIS(Mob) | 4 | 7.88 | 0.37 | 2 | 13.17 | 0.1 | 3 | 11.34 | 0.34 |
| ΔSIS(PS) | 3 | 18.44 | 0.2 | 3 | 11.93 | 0.47 | 6 | 0.81 | 0.2 |
| (B) WITH CLINICAL VARIABLES | |||||||||
| Δ9HPT(A) | 5 | 69.63 | 0.69 | 3 | 71.35 | 0.68 | 3 | 61.39 | 0.76 |
| Δ9HPT(U) | 3 | 4.19 | 0.28 | 3 | 0.1 | 0.22 | 3 | 1.51 | 0.9 |
| ΔARAT(A) | 16 | 5.14* | 0.96 | 8 | 5.72* | 0.95 | 16 | 7.01* | 0.92 |
| ΔBI | 3 | 0.05 | 0.1 | 7 | 4.59 | 0.64 | 8 | 3.82 | 0.75 |
| ΔSIS(ADL) | 4 | 9.45 | 0.43 | 5 | 13.38 | 0.22 | 4 | 14.1 | 0.13 |
| ΔSIS(HF) | 5 | 16.15* | 0.78 | 5 | 23.48* | 0.51 | 4 | 15.1* | 0.8 |
| ΔSIS(Mob) | 4 | 9.77 | 0.03 | 7 | 9.4 | 0.54 | 5 | 10.51 | 0.43 |
| ΔSIS(PS) | 4 | 16.36 | 0.37 | 4 | 13.52 | 0.32 | 8 | 12.53* | 0.41 |
Specific correlates are listed in Table 7. (
*
) = significant against chance-level based on permutation-test (p < 0.05); T4 = pre-therapy; T6 = post-therapy; T7 = 1-month post-therapy.